Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ART-001 by ARTham Therapeutics for Congenital Vascular Malformation: Likelihood of Approval
ART-001 is under clinical development by ARTham Therapeutics and currently in Phase I for Congenital Vascular Malformation. According to GlobalData,...